Current events involving politics, political office holders, political candidates, world events, local events, crime and other public affairs issues are discussed. Business news items as well as science and technology issues may appear.
Search This Blog
Wednesday, December 9, 2015
Merck Announces Samsung Bioepis Receives Approval of RENFLEXIS™ (Infliximab), a Biosimilar of Remicade, in Korea | Merck Newsroom Home
Samsung Bioepis’ Second Immunology Biosimilar Approved, to be Commercialized Under Partnership with Merck
No comments:
Post a Comment